XML 15 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended
Jun. 30, 2017
Jun. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (3,833,054) $ (899,378)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Provision for doubtful accounts, net of recoveries 6,642 167,496
Depreciation and amortization expense 155,267 164,658
Stock-based compensation expense 223,566 247,717
Amortization of deferred financing costs 53,667 37,926
Change in fair value of warrant liability 0 (822,222)
Changes in assets and liabilities:    
Accounts receivable 76,212 (774,087)
Other receivables (342,063) 265,980
Due from affiliates 18,314 453
Prepaid expenses and other current assets (13,564) (215,182)
Restricted cash 19,941 0
Other assets 3,379 2,762
Accounts payable and accrued liabilities 8,329,610 (317,451)
Deferred rent liability (31,956) 33,584
Medical liabilities 17,949,904 (158,668)
Net cash provided by (used in) operating activities 22,615,865 (2,266,412)
Cash flows from investing activities:    
Property and equipment acquired (36,081) (163,511)
Net cash used in investing activities (36,081) (163,511)
Cash flows from financing activities:    
Principal payments on lines of credit (37,500) (12,500)
Distributions to non-controlling interest shareholder 0 (450,000)
Proceeds from the exercise of warrants 0 132,002
Net cash used in financing activities (37,500) (330,498)
Net increase (decrease) in cash and cash equivalents 22,542,284 (2,760,421)
Cash and cash equivalents, beginning of period 8,664,211 9,270,010
Cash and cash equivalents, end of period 31,206,495 6,509,589
Supplementary disclosures of cash flow information:    
Interest paid 584 7,142
Income taxes paid $ 17,591 $ 16,400